# Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease

Study · id `cardio:ct-nct02177786` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02177786](<https://clinicaltrials.gov/study/NCT02177786>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02177786

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 334 participants.

## Technical summary

Registry record NCT02177786. Randomized; double masking; primary purpose treatment. Start 2014-06 (registry gives no type); primary completion 2016-07 (actual). Results posted on 2019-06-11.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 334 participants (enrolled count; ClinicalTrials.gov record NCT02177786, source copy `cardio:ctgov-nct02177786-2019-11-05`, retrieved 2026-10-26)
- Start date: 2014-06 (registry gives no type) (ClinicalTrials.gov record NCT02177786, source copy `cardio:ctgov-nct02177786-2019-11-05`, retrieved 2026-10-26)
- Primary completion: 2016-07 (actual) (ClinicalTrials.gov record NCT02177786, source copy `cardio:ctgov-nct02177786-2019-11-05`, retrieved 2026-10-26)
- Completion: 2016-08 (actual) (ClinicalTrials.gov record NCT02177786, source copy `cardio:ctgov-nct02177786-2019-11-05`, retrieved 2026-10-26)
- Results first posted: 2019-06-11 (ClinicalTrials.gov record NCT02177786, source copy `cardio:ctgov-nct02177786-2019-11-05`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT02177786, source copy `cardio:ctgov-nct02177786-2019-11-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02177786-2019-11-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease
- Condition: Diabetic Kidney Disease
- Intervention (Drug): Selonsertib
- Intervention (Drug): Placebo to match selonsertib
- Lead sponsor: Gilead Sciences
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Gilead Sciences (`cardio:org-gilead-sciences`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Effects of Selonsertib in Patients with Diabetic Kidney Disease (`cardio:pubmed-31506292`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 622f887718ac08b54b12ad078e49efc72bef9209e3aaaddb548c1cd995378b87
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
